January 23, 2023
A Massachusetts federal judge on Monday consolidated a pair of proposed class actions alleging that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal to keep a generic version of its anti-constipation drug Amitiza off the market for over six years.
June 28, 2021
Takeda Pharmaceutical broke antitrust law when it cut a pay-for-delay deal with Par Pharmaceuticals to keep a generic version of Takeda's anti-constipation drug Amitiza off the market for more than six years, according to a proposed class action in Massachusetts federal court.